{"public_id":"cl_9b0fb9959802d8a3c9cf8f00b23a997f","status":"active","superseded_by_public_id":null,"corpus_id":121120559,"text":"Cabergoline induces pituitary prolactinoma cell death mainly via the autophagic cell death pathway.","confidence":0.96,"paper":{"corpus_id":121120559,"title":"Bromocriptine and cabergoline induce cell death in prolactinoma cells via the ERK/EGR1 and AKT/mTOR pathway respectively","url":"https://sah.borca.ai/papers/121120559"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.96,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_62e05693d3b45f7b19e76d5d2f14109c","name":"autophagic cell death pathway","description":"A cell death program associated with autophagy-related degradation processes.","types":["pathway"],"url":"https://sah.borca.ai/concepts/co_62e05693d3b45f7b19e76d5d2f14109c"},{"public_id":"co_a769e95d05031ac92d64672095ed521e","name":"pituitary prolactinoma cell death","description":"Death of pituitary prolactinoma cells as a biological outcome.","types":["outcome"],"url":"https://sah.borca.ai/concepts/co_a769e95d05031ac92d64672095ed521e"},{"public_id":"co_f90d1c0f7185af829fa403fd5f44cef3","name":"cabergoline","description":"A dopamine agonist used to treat hyperprolactinemia and prolactinoma.","types":["drug"],"url":"https://sah.borca.ai/concepts/co_f90d1c0f7185af829fa403fd5f44cef3"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_9b0fb9959802d8a3c9cf8f00b23a997f"}